These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 38473840)

  • 1. The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis.
    Sohn M; Lim S
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vascular effects of cilostazol.
    Weintraub WS
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):56B-60B. PubMed ID: 16498513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol in the management of atherosclerosis.
    Sallustio F; Rotondo F; Di Legge S; Stanzione P
    Curr Vasc Pharmacol; 2010 May; 8(3):363-72. PubMed ID: 20180773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Cilostazol: A Critical Review of Its Antithrombotic and Cardiovascular Actions and Its Clinical Applications.
    Manolis AA; Manolis TA; Melita H; Mikhailidis DP; Manolis AS
    J Clin Pharmacol; 2022 Mar; 62(3):320-358. PubMed ID: 34671983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake.
    Liu Y; Shakur Y; Yoshitake M; Kambayashi Ji J
    Cardiovasc Drug Rev; 2001; 19(4):369-86. PubMed ID: 11830753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol: treatment of intermittent claudication.
    Reilly MP; Mohler ER
    Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol for intermittent claudication.
    Bedenis R; Stewart M; Cleanthis M; Robless P; Mikhailidis DP; Stansby G
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003748. PubMed ID: 25358850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospects of clinical application of cilostazol for peripheral artery disease].
    Burleva EP; Korelin SV
    Angiol Sosud Khir; 2020; 26(3):28-36. PubMed ID: 33063749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication.
    Grouse JR; Allan MC; Elam MB
    J Clin Pharmacol; 2002 Dec; 42(12):1291-8. PubMed ID: 12463722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.
    Lee SP; Suh JW; Park KW; Lee HY; Kang HJ; Koo BK; Chae IH; Choi DJ; Rha SW; Bae JW; Cho MC; Kwon TG; Bae JH; Kim HS;
    Trials; 2010 Aug; 11():87. PubMed ID: 20735821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cilostazol on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
    Geng DF; Deng J; Jin DM; Wu W; Wang JF
    Atherosclerosis; 2012 Jan; 220(1):177-83. PubMed ID: 22015232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of cilostazol on restenosis according to implanted stent type (from a pooled analysis of three DECLARE randomized trials).
    Lee SW; Ahn JM; Han S; Park GM; Cho YR; Lee WS; Jang JY; Kwon CH; Lee JY; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2013 Nov; 112(9):1328-34. PubMed ID: 23890573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol: a new drug in the treatment intermittent claudication.
    Kumar M; Bhattacharya V
    Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):181-5. PubMed ID: 18221117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple versus dual antiplatelet therapy in acute coronary syndromes: adding cilostazol to aspirin and clopidogrel?
    Niazi AK; Dinicolantonio JJ; Lavie CJ; O'Keefe JH; Meier P; Bangalore S
    Cardiology; 2013; 126(4):233-43. PubMed ID: 24107485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation.
    Kunishima T; Musha H; Eto F; Iwasaki T; Nagashima J; Masui Y; So T; Nakamura T; Oohama N; Murayama M
    Clin Ther; 1997; 19(5):1058-66. PubMed ID: 9385493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cilostazol in percutaneous coronary interventions.
    Rogers KC; Faircloth JM; Finks SW
    Ann Pharmacother; 2012 Jun; 46(6):839-50. PubMed ID: 22669796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
    Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
    J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
    Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
    Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention.
    Tanigawa T; Nishikawa M; Kitai T; Ueda Y; Okinaka T; Makino K; Ito M; Isaka N; Ikeda Y; Shiku H; Nakano T
    Am J Cardiol; 2000 May; 85(9):1054-9. PubMed ID: 10781751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.